Format

Send to

Choose Destination
BMC Evol Biol. 2017 Mar 7;17(1):70. doi: 10.1186/s12862-017-0913-3.

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy.

Author information

1
KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Herestraat 49 - box 1040, 3000, Leuven, Belgium. lize.cuypers@kuleuven.be.
2
KU Leuven - University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Herestraat 49 - box 1040, 3000, Leuven, Belgium.
3
National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
4
Department of Health Sciences, Institute of Microbiology, School of Medicine, University of "Magna Graecia", Viale Europa, Germaneto, 88100, Catanzaro, Italy.
5
Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
6
Global Health and Tropical Medicine, GHTM, Institute for Hygiene and Tropical Medicine, IHMT, University Nova de Lisboa, UNL, Rua da Junqueira 100, 1349-008, Lisbon, Portugal.
7
Molecular Biology and Immunology Department, Fundación Instituto de Immunología de Colombia (FIDIC), Basic Sciences Department, Universidad del Rosario, Bogotá, Colombia.
8
Luciad, Computer Software, Gaston Geenslaan 11, 3001, Heverlee, Belgium.
9
Department of Medical and Surgical Sciences, Unit of Infectious and Tropical Diseases, School of Medicine, University of "Magna Graecia", Viale Europa, Germaneto, 88100, Catanzaro, Italy.
10
KU Leuven - University of Leuven, Department of Clinical and Experimental Medicine, Hepatology, Leuven, Belgium.
11
University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium.

Abstract

BACKGROUND:

In-depth phylogeographic analysis can reveal migration patterns relevant for public health planning. Here, as a model, we focused on the provenance, in the current Italian HCV subtype 1a epidemic, of the NS3 resistance-associated variant (RAV) Q80K, known to interfere with the action of NS3/4A protease inhibitor simeprevir. HCV1a migration patterns were analysed using Bayesian phylodynamic tools, capitalising on newly generated and publicly available time and geo-referenced NS3 encoding virus genetic sequence data.

RESULTS:

Our results showed that both immigration and local circulation fuel the current Italian HCV1a epidemic. The United States and European continental lineages dominate import into Italy, with the latter taking the lead from the 1970s onwards. Since similar migration patterns were found for Q80K and other lineages, no clear differentiation of the risk for failing simeprevir can be made between patients based on their migration and travel history. Importantly, since HCV only occasionally recombines, these results are readily transferable to the genetic sequencing policy concerning NS5A RAVs.

CONCLUSIONS:

The patient migration and travel history cannot be used to target only part of the HCV1a infected population for drug resistance testing before start of antiviral therapy. Consequently, it may be cost-effective to expand genotyping efforts to all HCV1a infected patients eligible for simeprevir-based therapies.

KEYWORDS:

Europe; HCV; HCV1a; Italy; Phylogeography; Public health policy; Q80K; US

PMID:
28270091
PMCID:
PMC5341469
DOI:
10.1186/s12862-017-0913-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center